Neuroleptic Malignant Syndrome and Serotonin Syndrome
On this page
Direct answer
Neuroleptic malignant syndrome is a rare, potentially fatal reaction to dopamine-blocking drugs, marked by hyperthermia, lead-pipe rigidity and autonomic instability. Serotonin syndrome is excess serotonergic activity, usually appearing within hours of a new or increased serotonergic drug, and it is marked by clonus, hyperreflexia and agitation. The two are separated by onset, reflex pattern and drug history, and treatment starts with stopping the offending agent and supportive care.
What you must remember
- NMS precipitants: dopamine D2 antagonists such as haloperidol, metoclopramide and prochlorperazine, or abrupt withdrawal of dopaminergic drugs such as levodopa.
- NMS features: fever, lead-pipe rigidity, altered consciousness, autonomic instability and raised creatine kinase, developing over days.
- NMS reflexes: normal or reduced, with no clonus, which is the key bedside distinction from serotonin syndrome.
- Serotonin precipitants: SSRIs, SNRIs, MAOIs, linezolid, tramadol, triptans, fentanyl and MDMA, especially in combination.
- Serotonin features: inducible or ocular clonus, hyperreflexia, tremor, agitation, diarrhoea and mydriasis, with onset usually within hours.
- Hunter criteria: serotonin toxicity is diagnosed when a serotonergic agent is present together with spontaneous clonus, inducible or ocular clonus with agitation or sweating, or tremor with hyperreflexia.
- NMS treatment: stop the drug, cool the patient, give fluids and benzodiazepines, and use dantrolene or bromocriptine in severe cases.
- Serotonin treatment: stop all serotonergic drugs, give benzodiazepines for agitation and muscle activity, and consider oral cyproheptadine for moderate to severe cases.
Neuroleptic malignant syndrome and serotonin syndrome compared
Both syndromes cause fever and altered mental status, so the examination and the timeline do most of the work in separating them.
| Feature | Neuroleptic malignant syndrome | Serotonin syndrome |
|---|---|---|
| Typical trigger | D2 blockers or abrupt dopaminergic withdrawal | A serotonergic drug, often new or increased |
| Onset | Over days | Usually within hours |
| Muscle tone | Lead-pipe rigidity | Hypertonia, mainly in the lower limbs |
| Reflexes and clonus | Normal or reduced; no clonus | Hyperreflexia with inducible or ocular clonus |
| Other features | Raised creatine kinase, autonomic instability | Agitation, tremor, diarrhoea, mydriasis |
| Key treatment | Stop the drug; dantrolene or bromocriptine if severe | Stop serotonergic drugs; benzodiazepines, cyproheptadine |
Clonus and hyperreflexia point to serotonin toxicity, while lead-pipe rigidity with normal reflexes points to neuroleptic malignant syndrome. Both can be fatal, so the timeline and the drug list matter more than any single sign.
Both need admission to a monitored bed in the early phase, with continuous temperature, creatine kinase and urine output tracking. A wrong guess delays the right drug, so the history of recent prescriptions should be taken before the diagnosis is settled.
Where the exam tries to catch you
Most lost marks come from confusing rigidity with clonus, or from treating either syndrome with the wrong drug.
- Trap: giving dantrolene for serotonin syndrome Correct: dantrolene is not the treatment for serotonin toxicity; stop the drugs and give supportive care with benzodiazepines.
- Trap: calling lead-pipe rigidity with normal reflexes serotonin syndrome Correct: rigidity without clonus, a D2 blocker history and a slow onset point to neuroleptic malignant syndrome.
- Trap: using an antipsychotic to calm agitation in serotonin syndrome Correct: antipsychotics add dopamine blockade and can worsen the picture, so benzodiazepines are preferred.
- Trap: giving paracetamol for the fever of either syndrome Correct: the hyperthermia comes from muscle activity and autonomic failure, not a raised hypothalamic set point, so active cooling is needed.
Frequently asked questions
What is the main reflex difference between NMS and serotonin syndrome?
Neuroleptic malignant syndrome typically shows normal or reduced reflexes with lead-pipe rigidity and no clonus. Serotonin syndrome shows hyperreflexia with inducible or ocular clonus, so reflex examination is the key bedside distinction.
Which drugs precipitate neuroleptic malignant syndrome?
Dopamine D2 antagonists such as haloperidol, metoclopramide and prochlorperazine precipitate neuroleptic malignant syndrome. Abrupt withdrawal of dopaminergic drugs such as levodopa can also trigger it, so the drug history should be taken carefully.
How is serotonin syndrome treated?
Serotonin syndrome is treated by stopping all serotonergic drugs, giving supportive care and using benzodiazepines for agitation and muscle activity. Cyproheptadine, a serotonin antagonist given orally, is considered in moderate to severe cases.
Why are antipyretics ineffective in these hyperthermic syndromes?
Antipyretics are ineffective in neuroleptic malignant syndrome and serotonin syndrome because the fever comes from muscle activity and autonomic dysfunction, not a raised hypothalamic set point. Active cooling and control of muscle activity are therefore the priorities.
Which drug combinations commonly cause serotonin syndrome?
Combining an MAOI with an SSRI, or adding linezolid, tramadol or a triptan to an SSRI, commonly causes serotonin syndrome. Fentanyl and MDMA are also serotonergic, so the drug history should be reviewed before the diagnosis is made.